A study found that Apple’s Watch and iPhone can remotely assess the weakness of cardiovascular patients. It is reported that this research was conducted by Stanford University and funded by Apple.
The researchers conducted a 6-month follow-up survey of over 100 volunteers who participated in the study and gave them iPhones and Apple Watches running the VascTrac research application.
The study compared traditional walking tests with measurements in outpatient clinics using iPhone and Apple Watch sensors and walking tests performed remotely through apps.
The research results display that iPhone and Apple Watch can remotely monitor and evaluate the weakness and functional ability of patients with cardiovascular diseases.
As a smartwatch, the health tracking function of the Apple Watch is one of its main features. In recent years, Apple has also added new health features to Apple Watch, such as measuring blood oxygen levels, heart rate, and electrocardiogram.
There are rumors that Apple intends to add blood glucose monitoring to Apple Watch. In January this year, Apple plans to introduce blood glucose monitoring in the upcoming Apple Watch Series 7. It is reported that Apple Watch Series 7 is expected to be available later this year.
Additionally, Apple is also considering continuous monitoring of the wearer’s blood pressure through Apple Watch. Last month, two independent studies showed that the Apple Watch can be detected seven days before the onset of symptoms of the new coronavirus infection, and the success rate is quite high.
(Via)
